The utility and safety of real-time endoscopic-guided mucosal admittance(MA) measurement in patients with inflammatory bowel disease(IBD).
Not Applicable
Recruiting
- Conditions
- Inflammatory bowel disease (IBD)
- Registration Number
- JPRN-UMIN000024825
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who have a history of pacemaker or ICD implantation. 2. Patients who have a history of electrical device implantation to b rain such as deep brain stimulation. 3. Patients who have severe disorder of cardiovascular, liver or renal function, infection, and hematopoietic organ. 4. Patients who are judged as being inappropriate for this study by their medical doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical utility of MA in patients with IBD.
- Secondary Outcome Measures
Name Time Method